{"address1": "100 Campus Drive", "address2": "6th Floor", "city": "Marlborough", "state": "MA", "zip": "01752", "country": "United States", "phone": "855 896 8401", "fax": "855 404 0061", "website": "https://www.akoyabio.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.", "fullTimeEmployees": 205, "companyOfficers": [{"maxAge": 1, "name": "Mr. Brian  McKelligon", "age": 55, "title": "President, CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 854986, "exercisedValue": 0, "unexercisedValue": 3408928}, {"maxAge": 1, "name": "Mr. John Frederick Ek CPA", "age": 47, "title": "CFO, Principal Financial Officer & Principal Accounting Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 496762, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anthony  Catalano", "title": "Senior Vice President of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Priyam  Shah", "title": "Senior Director of Business Development & Investor Relations Strategy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Kamocsay", "age": 53, "title": "Chief Legal Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Niro  Ramachandran Ph.D.", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 298181, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pascal  Bamford Ph.D.", "title": "Senior Vice President of Research & Development and Laboratory Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rob C. Hart C.F.A., CFA, J.D.", "title": "Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.39, "open": 1.42, "dayLow": 1.34, "dayHigh": 1.48, "regularMarketPreviousClose": 1.39, "regularMarketOpen": 1.42, "regularMarketDayLow": 1.34, "regularMarketDayHigh": 1.48, "payoutRatio": 0.0, "beta": 1.322, "forwardPE": -2.4545455, "volume": 200327, "regularMarketVolume": 200327, "averageVolume": 679596, "averageVolume10days": 146500, "averageDailyVolume10Day": 146500, "bid": 1.04, "ask": 1.71, "bidSize": 2, "askSize": 1, "marketCap": 67252144, "fiftyTwoWeekLow": 1.32, "fiftyTwoWeekHigh": 4.65, "priceToSalesTrailing12Months": 0.82344186, "fiftyDayAverage": 2.0644, "twoHundredDayAverage": 2.419475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 116358080, "profitMargins": -0.67789, "floatShares": 15377811, "sharesOutstanding": 49816400, "sharesShort": 2488423, "sharesShortPriorMonth": 3246458, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.05, "heldPercentInsiders": 0.67210996, "heldPercentInstitutions": 0.69831, "shortRatio": 6.77, "shortPercentOfFloat": 0.082200006, "impliedSharesOutstanding": 49816400, "bookValue": 0.153, "priceToBook": 8.82353, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -55365000, "trailingEps": -1.12, "forwardEps": -0.55, "enterpriseToRevenue": 1.425, "enterpriseToEbitda": -3.47, "52WeekChange": -0.6882217, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.35, "targetHighPrice": 5.0, "targetLowPrice": 1.8, "targetMeanPrice": 3.14, "targetMedianPrice": 3.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 5, "totalCash": 35040000, "totalCashPerShare": 0.703, "ebitda": -33530000, "totalDebt": 84146000, "quickRatio": 1.658, "currentRatio": 2.606, "totalRevenue": 81672000, "debtToEquity": 1107.913, "revenuePerShare": 1.653, "returnOnAssets": -0.16858, "returnOnEquity": -1.80445, "grossProfits": 47878000, "freeCashflow": -26517124, "operatingCashflow": -44103000, "revenueGrowth": -0.194, "grossMargins": 0.58622, "ebitdaMargins": -0.41054, "operatingMargins": -0.26837, "financialCurrency": "USD", "symbol": "AKYA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Akoya BioSciences, Inc.", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_530456307", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Akoya Biosciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1618579800000, "regularMarketChange": -0.03999996, "regularMarketDayRange": "1.34 - 1.48", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 679596, "fiftyTwoWeekLowChange": 0.029999971, "fiftyTwoWeekLowChangePercent": 0.022727251, "fiftyTwoWeekRange": "1.32 - 4.65", "fiftyTwoWeekHighChange": -3.3000002, "fiftyTwoWeekHighChangePercent": -0.70967746, "fiftyTwoWeekChangePercent": -68.82217, "earningsTimestamp": 1742241600, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "earningsCallTimestampStart": 1731621600, "earningsCallTimestampEnd": 1731621600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.12, "epsForward": -0.55, "epsCurrentYear": -0.59985, "priceEpsCurrentYear": -2.2505627, "fiftyDayAverageChange": -0.71439993, "fiftyDayAverageChangePercent": -0.34605694, "twoHundredDayAverageChange": -1.069475, "twoHundredDayAverageChangePercent": -0.44202772, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-04-16", "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "regularMarketChangePercent": -2.877695, "regularMarketPrice": 1.35, "marketState": "PRE", "displayName": "Akoya Biosciences", "trailingPegRatio": null}